Skip to main content
Erschienen in: Antimicrobial Resistance & Infection Control 1/2015

Open Access 01.12.2015 | Poster presentation

Outbreak of bacterial phlebitis related to peripheral intravenous catheters at a general hospital in Brazil

verfasst von: B Quental, R Saad, L Duarte, J Oliveira, A Frazilio

Erschienen in: Antimicrobial Resistance & Infection Control | Sonderheft 1/2015

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Introduction

Device related infections are prevalent all over the world. Peripheral intravenous catheters are the most used intravascular devices and the less associated with infections.

Objectives

To describe the investigation and control measures of an outbreak of bacterial phlebitis at a general hospital in São Paulo, Brazil.

Methods

Bacterial phlebitis was defined according to the Centers for Disease Control criteria. Each patient’s data were collected from their medical files. After tabulation of the data, we could find common factors and propose control measures.

Results

From January to June, 2013, 11 cases of bacterial phlebitis related to peripheral Intravenous catheters were reported. We could not find only one factor associated. Most of the cases occurred after 2 days of the punction (42%), and 72% of them were performed at the emergency department. We noticed that 37% of these catheters were manipulated in the ICU and 48% of the punctures were localized at the antecubital fossa. Of these cases, only one patient cursed with bloodstream infection, and this was due to Staphylococcus aureus methicillin sensible. We performed observational auditing of insertion and manipulation of these catheters, and we could notice that the most frequent process problems were hand hygiene and hub disinfection. There was no change in the kind of material used in the hospital. Based on these findings, we proposed several measures for infection control, including a hand hygiene campaign, discussion of every case with the multiprofessional team, a global training of 100% of the health care team regarding punction and manipulation of the catheters, reinforcement of daily evaluation of the need of maintaining the catheter and priorization of more distal punction. The outbreak was controlled in august, 2013.

Conclusion

Active infection control programs, including infection surveillance and implementation of prevention measures are important for all types of intravascular devices, including peripheral Intravenous catheters, in order to improve patient safety.

Disclosure of interest

None declared.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
The Creative Commons Public Domain Dedication waiver (https://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Metadaten
Titel
Outbreak of bacterial phlebitis related to peripheral intravenous catheters at a general hospital in Brazil
verfasst von
B Quental
R Saad
L Duarte
J Oliveira
A Frazilio
Publikationsdatum
01.12.2015
Verlag
BioMed Central
DOI
https://doi.org/10.1186/2047-2994-4-S1-P215

Weitere Artikel der Sonderheft 1/2015

Antimicrobial Resistance & Infection Control 1/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.